In this regard, Guo and co-workers demonstrated a decreased binding of KLF6 to its DNA binding sequence on the Tissue Factor Pathway Inhibitor-2 (TFPI-2) gene due to CpG hypermethylation in highly invasive breast cancer cell lines, suggesting a tumor suppressor function of KLF6 [30]. Here, TFPI2 is linked to breast carcinoma.